Create Account
Sign In
Dark
chart
exchange
Terminal
Screener
Stocks
Crypto
Forex
Watchlists
Trends
New

CALA
Calithera Biosciences Inc
stock NASDAQ

At Close
5/20/2022 3:59:59 PM EDT
0.2331USD+12.067%(+0.0251)2,157,348
0.2050Bid   0.2820Ask   0.0770Spread IEX
Pre-market
1969-12-31
0.00USD-100.000%(-0.21)0
After-hours
1969-12-31
0.00USD0.000%(0.00)0
OverviewOption ChainHistoricalExchange VolumeShort VolumeFailure to DeliverTrendsNewsMore
open chart   
open chart   
Market Cap
22.666M
CEO
Susan Molineaux
Headquarters
South San Francisco, California, USA
Industry
Biotechnology
Next Earnings
2022-08-04 (74d)
Related
ORPNPIRSCSBRELOXXLV
Jan 31, 2022
10:29AM EST  Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2022   Benzinga
07:57AM EST  Ladenburg Thalmann Initiates Coverage On Calithera Biosciences with Buy Rating, Announces Price Target of $4   Benzinga
Jan 20, 2022
10:41AM EST  Benzinga's Top Ratings Upgrades, Downgrades For January 20, 2022   Benzinga
07:40AM EST  The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.25 A.M. ET).   RTTNews
06:15AM EST  SVB Leerink Upgrades Calithera Biosciences to Outperform, Raises Price Target to $3   Benzinga
More News
Stats
Avg. Vol. 10 Day
6,437,928
Avg. Vol. 30 Day
5,106,803
Employees
63
Market Cap
22,665,752
Shares Out.
97,236,174
Float
66,847,820
On/Off Exchange
42%/58%
6 Month Beta
2.71
1 Year Beta
2.36
2 Year Beta
1.71
3 Year Beta
1.50
52 Week Low
0.15
52 Week High
2.59
SMA50
0.28
SMA200
0.58
1 Week
+8.42%
1 Month
-26.77%
3 Month
-51.00%
6 Month
-74.30%
1 Year
-88.95%
2 Year
-96.28%
5 Year
-98.59%
Profile
Calithera Biosciences is a clinical-stage biopharmaceutical company pioneering the discovery and development of targeted therapies that disrupt cellular metabolic pathways to preferentially block tumor cells and enhance immune-cell activity. Driven by a commitment to rigorous science and a passion for improving the lives of people impacted by cancer and other life-threatening diseases, Calithera is advancing a pipeline of first-in-clinic, oral therapeutics to meaningfully expand treatment options available to patients. Calithera is headquartered in South San Francisco, California.

CALA Stock Summary

Calithera Biosciences Inc (NASDAQ:CALA) stock price today is $0.2331, and today's volume is 2,157,348. CALA is up 12.067% today. The 30 day average volume is 5,106,803. CALA market cap is 22.666M with 97,236,174 shares outstanding.



Share
About
Symbol List

Pricing
Disclaimer

ChartExchange on Twitter @chartexchange_
© 2020 - 2022 ChartExchange LLC